18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based survey.

18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based survey.

Show other versions (1)

<h4>Introduction</h4>Population-based HIV-free survival at 18-24 months of age among HIV-exposed infants in high prevalence settings in the era of treatment for all is largely unknown. We conducted a community-based survey to determine outcomes of HIV-exposed infants at 18-24 months in L...

Full description

Bibliographic Details
Main Authors: Appolinaire Tiam, Michelle M Gill, Rhoderick Machekano, Vincent Tukei, Majoalane Mokone, Shannon Viana, Mosilinyane Letsie, Mots'oane Tsietso, Irene Seipati, Cecilia Khachane, Marethabile Nei, Florence Mohai, Thorkild Tylleskär, Laura Guay
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0237409

Internet

https://doi.org/10.1371/journal.pone.0237409

Similar Items